Masamichi Isobe
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 31
- Acute Myeloid Leukemia Research 10
- Immunology top 10%
- Immune Cell Function and Interaction 12
- Immune Response and Inflammation 8
- T-cell and Retrovirus Studies 4
- Immunology and Allergy top 10%
- Transplantation top 10%
-
- Transplantation: Methods and Outcomes 10
-
- Antifungal resistance and susceptibility 4
-
- Chemokine receptors and signaling 4
- Co-authors
- Arinobu TojoTakaaki KonumaSeiko KatoSatoshi TakahashiMaki Oiwa‐MonnaToshio KitamuraJiro KitauraAyako Kaitani
- Journals
- Journal of Biological Chemistry (2 papers)SHILAP Revista de lepidopterología (3 papers)Blood (3 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Masamichi Isobe
62 papers receiving 725 citations
Peers
Comparison fields: 5 of 82
- Hematology 256
- Immunology 342
- Immunology and Allergy 72
- Transplantation 22
- Genetics 53
Countries citing papers authored by Masamichi Isobe
This map shows the geographic impact of Masamichi Isobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masamichi Isobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masamichi Isobe more than expected).
Fields of papers citing papers by Masamichi Isobe
This network shows the impact of papers produced by Masamichi Isobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masamichi Isobe. The network helps show where Masamichi Isobe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masamichi Isobe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 3 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 20 | |
| 11 | 2019 | 5 | |
| 12 | 2019 | 71 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 0 | |
| 15 | 2019 | 2 | |
| 16 | 2019 | 13 | |
| 17 | 2018 | 8 | |
| 18 | 2013 | 26 | |
| 19 | 2010 | 23 | |
| 20 | 2000 | 3 |
About Masamichi Isobe
Masamichi Isobe is a scholar working on Hematology, Immunology and Transplantation, having authored 66 papers that have together received 728 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (31 papers), Immune Cell Function and Interaction (12 papers), Transplantation: Methods and Outcomes (10 papers), Acute Myeloid Leukemia Research (10 papers), Immune Response and Inflammation (8 papers), T-cell and Retrovirus Studies (4 papers), Antifungal resistance and susceptibility (4 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Hematology (256 citations), Immunology (342 citations) and Immunology and Allergy (72 citations). Masamichi Isobe has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Arinobu Tojo, Takaaki Konuma, Seiko Kato, Satoshi Takahashi, Maki Oiwa‐Monna, Toshio Kitamura, Jiro Kitaura, Ayako Kaitani, Kumi Izawa and Akie Maehara. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.